Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine

NCT06981195 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT06981195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06981195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Recruiting
Start date
May 27, 2025
Completion date
July 30, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, opioid use, opioid use disorder, orexin antagonist